Academic History
Joshua Sabari, MD, is a Thoracic Oncologist at the Perlmutter Cancer Center, and Assistant Professor of Medicine at NYU Grossman School of Medicine, New York, NY. Dr Sabari completed his medical degree at the George Washington University School of Medicine and Health Sciences, Washington, DC, followed by a residency in internal medicine at New York-Presbyterian Hospital and Weill Cornell Medical Center, New York, NY. Dr Sabari subsequently pursued specialized training in medical oncology, completing his fellowship at Memorial Sloan Kettering Cancer Center, New York, NY.
Speaking on innovative lung cancer therapies
Dr Sabari has authored numerous peer-reviewed articles, particularly in the field of lung cancer. His research has been published in prominent journals, including Journal of Clinical Oncology and The Lancet Oncology. His work often focuses on advancing treatment options for lung cancer patients, with a specific interest in those with EGFR exon 20 insertion mutations. Dr Sabari’s contributions to the field have helped shape emerging therapies and clinical strategies for patients with these mutations.
Dr Sabari’s contributions have been recognized at major conferences, including the American Society of Clinical Oncology (ASCO) and the European Society for Medical Oncology (ESMO). His ongoing investigations continue to shape therapeutic strategies for lung cancer, particularly in areas of targeted therapy, immunotherapy, and combination treatment modalities.
Sorry, no posts matched your criteria.
